INVO Bioscience, Inc. INVO
0.83 0.00 (+0.00%)
At closeOct 21, 2024, 4:00 PM EDT
0.8171 Day range 0.88
52-week range unavailable
- Market cap
- 3.25M
- Revenue (ttm)
- 5.77M
- Profit margin
- -122.80%
- Shares out
- 3.91M
- Forward P/E
- -4.17
- Volume
- 124.02K
- Open
- 0.8636
- Previous close
- 0.833
- Day's range
- 0.8171 – 0.88
- Beta
- 1.44
- Analysts
- Hold
- Earnings date
- Nov 11, 2024
2Y -23.0670 (-96.51%)
Key statistics
- Enterprise value
- 16.78M
- PEG ratio
- 0.00
- Price / sales
- 0.56
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 481.40%
- Free cash flow
- 1.44M
- Total cash
- 942.93K
- Total debt
- 5.38M
- Return on equity
- 0.00%
- Short % of float
- 0.05%
- 50-day average
- 0.773565
- 200-day average
- 0.901579
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 11, 2024
Expected Nov 11, 2024. Consensus EPS estimate 0.00.
Financials — quick view
INVO Revenue — quarterly 1.84M
INVO Net income — quarterly -2.25M
INVO EPS — quarterly -0.62
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
About INVO Bioscience, Inc.
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- invobioscience.com
News
INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026 
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference 
INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference 
INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International 
INVO Fertility Stock Surges Following Q2 Earnings Beat 
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability 
Why INVO Fertility Stock Is Surging Friday Afternoon 
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure 
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q 
INVO Fertility Announces Fiscal Year 2025 Financial Results
Your note
Sign in to keep a note on INVO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.38% | 54,058 | 45.03K | Jun 29, 2024 |
| Geode Capital Management, LLC | 0.83% | 32,614 | 27.17K | Jun 29, 2024 |
| Two Sigma Securities, LLC | 0.41% | 15,968 | 13.30K | Jun 29, 2024 |
| Virtu Financial LLC | 0.32% | 12,409 | 10.34K | Jun 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.13% | 5,106 | 4.25K | Jun 29, 2024 |
| Osaic Holdings Inc | 0.01% | 250 | 208 | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.38% | 54,058 | 45.03K | Jun 29, 2024 |
| Fidelity Extended Market Index Fund | 0.50% | 19,530 | 16.27K | Aug 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.16% | 6,166 | 5.14K | Aug 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.13% | 5,055 | 4.21K | Aug 30, 2024 |
| Fidelity Total Market Index Fund | 0.03% | 1,199 | 998 | Aug 30, 2024 |